Compassionate Use of Vidutolimod

Regeneron Pharmaceuticals

Status

Conditions: Refractory Melanoma

Treatments: Drug: Vidutolimod

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT06063746

CMP-001-Vidutolimod

Details and patient eligibility

About

Provide Compassionate Use of Vidutolimob

Full description

Compassionate use is only available to patients who transitioned from a previous vidutolimod (CMP-001) study.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

-

Exclusion criteria

-